Riskpilot← Back to searchSign inGet full accessPURE HOLDING AS
ASActiveOrg 989241028Flatåstoppen 15, 7079 FlatåsenWholesale of pharmaceutical and medical goods · NACE 4646Est. 20060 employees
Revenue 2024
NOK 0
EBITDA margin
—
-14% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK 1,2M
+133% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -17K | -14% |
| Net profit | NOK 1,2M | +133% |
| Total assets | NOK 5,6M | +26% |
| Equity | NOK 5,6M | +26% |
| Employees | 0 | — |
Legal name
PURE HOLDING AS
Org number
989241028
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. februar 2006
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Kjøp og salg av aksjer og andeler, kjøp og salg av fast eiendom, samt deltakelse i annen virksomhet med likelydende aktiviteter.
Address
Flatåstoppen 15, 7079 Flatåsen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −30 | −17 | −20 | −14 | −17 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −30 | −17 | −20 | −14 | −17 |
| Net financials | 872 | 1 446 | −288 | 518 | 1 189 |
| Profit before tax | 841 | 1 429 | −308 | 504 | 1 173 |
| Tax | 25 | −0 | −0 | −0 | −0 |
| Net profit | 816 | 1 429 | −308 | 504 | 1 173 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 672 | 4 591 | 3 948 | 4 450 | 5 623 |
| Equity | 3 625 | 4 254 | 3 946 | 4 450 | 5 623 |
| Long-term debt | 43 | 35 | 0 | 0 | 0 |
| Short-term debt | 4 | 302 | 2 | −0 | 0 |
| Total debt | 47 | 337 | 2 | −0 | 0 |
EBITDA margin
-1652900.0%
This company
15.8%
Market median
-10461492% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
20.9%
This company
18.4%
Market median
+14% vs market
20202024
Net profit margin
117272700.0%
This company
8.1%
Market median
+1447811011% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LA Deputy Member | Deputy Member | 2012 – 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PURE HOLDING AS 
PURE MEDICAL ASBoard members of PURE HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Aage Folde | Deputy Member | 0 companies |
| Knut Johan Dahle | Chairman | 0 companies |